{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:19:27Z","timestamp":1758050367277,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jcjo.2014.07.010","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T01:15:40Z","timestamp":1412212540000},"page":"e127-e129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Peripheral retinal ischemia after intravenous tissue plasminogen activator for central retinal artery occlusion"],"prefix":"10.1016","volume":"49","author":[{"given":"Anthony","family":"Joseph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Rahimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2014.07.010_bib1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0161-6420(82)34626-6","article-title":"Ophthalmologic findings in 70 patients with evidence of retinal embolism","volume":"89","author":"Arruga","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.07.010_bib2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/eye.2013.25","article-title":"A review of central retinal artery occlusion: clinical presentation and management","volume":"27","author":"Varma","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2014.07.010_bib3","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","article-title":"Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial","volume":"42","author":"Chen","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jcjo.2014.07.010_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","article-title":"Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial","volume":"117","author":"Schumacher","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.07.010_bib5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00417-005-0140-2","article-title":"Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1: EAGLE Study report no. 1","volume":"244","author":"Feltgen","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.07.010_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001989.pub2","article-title":"Interventions for acute non-arteritic central retinal artery occlusion","author":"Fraser","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.jcjo.2014.07.010_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/WNO.0b013e31814b1f66","article-title":"Thrombolysis for central retinal artery occlusion","volume":"27","author":"Biousse","year":"2007","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jcjo.2014.07.010_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11940-012-0202-9","article-title":"Treatment options for central retinal artery occlusion","volume":"15","author":"Cugati","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jcjo.2014.07.010_bib9","first-page":"1234","article-title":"Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion","volume":"120","author":"Kattah","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.07.010_bib10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ajo.2008.06.016","article-title":"Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion","volume":"146","author":"Hattenbach","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.07.010_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1747-4949.2010.00545.x","article-title":"Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion","volume":"6","author":"Chen","year":"2011","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jcjo.2014.07.010_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajo.2008.07.025","article-title":"Thrombolysis for acute central retinal artery occlusion: is it time?","volume":"146","author":"Biousse","year":"2008","journal-title":"Am J Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418214002580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418214002580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:04:13Z","timestamp":1757793853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418214002580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0008418214002580"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2014.07.010","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral retinal ischemia after intravenous tissue plasminogen activator for central retinal artery occlusion","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2014.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}